
    
      This study is a multicenter, single-arm, open-label study of CLS2702C/D in patients who plan
      to undergo ESD for superficial esophageal cancer.

      In this study, the efficacy and safety of CLS2702C (cell sheet) transplanted (applied) to the
      wound site after ESD using CLS2702D (transplantation device) will be evaluated.
    
  